CancerNCT06559917
Effectiveness on Family Cohesion and Happiness of Using Social Media to Enhance Happiness Accounts for Late-Stage Cancer Patients and Their Families
A study testing life review in people with Cancer, run by YANG WEN-CHI.
Trial summary
The study period is from September 1, 2024, to December 31, 2025. The subjects are cancer patients from the medical center of this hospital. A block randomization will be used to assign 100 patients to the experimental group and 100 patients to the control group, totaling 200 patients. Read more about this study
- Who is it for?
- Ages 20 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cancer
- What is being tested?
- life review
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 1 Sep 2024to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- -
- Patients diagnosed with stage III or IV cancer by a specialist physician.
- Patients who agree to participate in the study after being informed about the research.
- Patients who are conscious and able to communicate in Mandarin or Taiwanese.
- Patients aged 20 years or older.
- Patients with no history of mental illness.
Show all 12Show fewer
- The primary caregiver of a patient diagnosed with stage III or IV cancer by a specialist physician.
- The primary caregiver who has a blood, marital, or cohabitation relationship with the patient.
- Family members who agree to participate in the study after being informed about the research.
- Family members who are conscious and able to communicate in Mandarin or Taiwanese.
- Family members aged 20 years or older.
- Family members with no history of mental illness.
Who cannot join
- -
- Patients in the experimental group and control group who reside in the same ward.
- Patients who share a ward with subjects already included in the study.
- Patients involved in ongoing medical disputes.
- Patients who cannot understand the study explanation due to language or cognitive impairments.
- Patients with a life expectancy shorter than the planned study duration.
Show all 11Show fewer
- Family members who do not have direct living or caregiving contact with the patient.
- Family members who cannot visit the patient regularly or participate in the study.
- Family members who cannot understand the study explanation due to language or cognitive impairments.
- Family members with significant visual or hearing impairments who do not use assistive devices and cannot resolve communication issues.
- Family members who cannot make independent decisions.
About this study
The study period is from September 1, 2024, to December 31, 2025. The subjects are cancer patients from the medical center of this hospital. A block randomization will be used to assign 100 patients to the experimental group and 100 patients to the control group, totaling 200 patients. During the study process, questionnaires and medical records of the subjects will be collected. The experimental group will receive the social media "Happiness Ledger" intervention, while the control group will receive routine treatment. Questionnaires will be collected from both groups before and after the intervention.
- Conditions
- Cancer
- Being tested
- life review
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
life reviewOther
After consenting, they will complete the first questionnaire before receiving the "Happiness Ledger" intervention via social media. Family members will have one week to organize photos, after which patients will share the meaning of the photos. This process will be recorded by the researcher and will last approximately 40 to 60 minutes. The researcher will then create a three-minute video using the photos, and the participating family members will assist in uploading the photos to the family LINE group as feedback to the subjects. The second questionnaire will then be completed.
| Study group | Role | What they receive |
|---|---|---|
| Experimental Group | Experimental | Upon admission to the cancer-related ward, after explaining the purpose and process of the study, patients who agree to participate in the study will complete the first questionnaire before the intervention with the social media "Happiness Ledger". The family members will have one week to organize photos, after which the patients will share the meaning of the photos. The process will be recorded by the researcher and will last approximately 40 to 60 minutes. Afterward, the researcher will create a video of about three minutes using the photos and ask the participating family members to assist in uploading the photos to the family LINE group as feedback to the research subjects. The patients will then complete the second questionnaire. Receives: Other: life review |
| Control Group | No intervention | After explaining the purpose and process of the study to the patients and their family members on the day of admission, and obtaining their consent to participate in the study, they will complete the first questionnaire. One week later, they will complete the second questionnaire. After the entire study is completed, the control group will receive the same social media "Happiness Ledger" intervention as the experimental group. Data collection will be conducted for both groups before and after the intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Family Cohesion
This study uses the Family Adaptability and Cohesion Evaluation Scale (FACES II) developed by Olson et al. (1979), which consists of 30 items to measure the family cohesion of patients and their families .
Measured: Baseline (pre-intervention) and 1 week after intervention
Secondary outcomes (1)
Happiness
This study uses the Subjective Happiness Scale (SHS) created by Lyubomirsky \& Lepper (1999), which consists of 4 items to measure the happiness of patients and their families."
Measured: Baseline and 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Aug 2024
- Study start1 Sep 2024 (estimated)
- Primary completion31 Dec 2024 (estimated)
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- YANG WEN-CHI
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, YANG WEN-CHI, Tri-Service General Hospital (TSGH)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06559917
- Sponsor's protocol ID
- A202405117
- Status last verified
- Aug 2024
- First submitted
- 6 Aug 2024
- Last updated
- 19 Aug 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Yang WC, Li CY, Ho CL, Chang PY, Wu LF, Pan HH. Effectiveness of a Social Media-Based Life Review Intervention on Happiness in Advanced Cancer Patients and Their Family Caregivers: A Mixed-Methods Study. Psychooncology. 2026 Jan;35(1):e70374. doi: 10.1002/pon.70374.
PubMed 41478730
Study at a glance
From the registry record, last updated by the sponsor on 19 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness on Family Cohesion and Happiness of Using Social Media to Enhance Happiness Accounts for Late-Stage Cancer Patients and Their Families
- ClinicalTrials.gov ID
- NCT06559917
- Acronym / sponsor ID
- A202405117
- Conditions
- Cancer
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- YANG WEN-CHIUniversity, hospital or other
- Study start
- 1 Sep 2024 (estimated)
- Primary completion
- 31 Dec 2024 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 19 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study period is from September 1, 2024, to December 31, 2025. The subjects are cancer patients from the medical center of this hospital. A block randomization will be used to assign 100 patients to the experimental group and 100 patients to the control group, totaling 200 patients. During the study process, questionnaires and medical records of the subjects will be collected. The experimental group will receive the social media "Happiness Ledger" intervention, while the control group will receive routine treatment. Questionnaires will be collected from both groups before and after the intervention.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental Group | Experimental | Other: life reviewUpon admission to the cancer-related ward, after explaining the purpose and process of the study, patients who agree to participate in the study will complete the first questionnaire before the intervention with the social media "Happiness Ledger". The family members will have one week to organize photos, after which the patients will share the meaning of the photos. The process will be recorded by the researcher and will last approximately 40 to 60 minutes. Afterward, the researcher will create a video of about three minutes using the photos and ask the participating family members to assist in uploading the photos to the family LINE group as feedback to the research subjects. The patients will then complete the second questionnaire. |
| Control Group | No intervention | –After explaining the purpose and process of the study to the patients and their family members on the day of admission, and obtaining their consent to participate in the study, they will complete the first questionnaire. One week later, they will complete the second questionnaire. After the entire study is completed, the control group will receive the same social media "Happiness Ledger" intervention as the experimental group. Data collection will be conducted for both groups before and after the intervention. |
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (12 listed)
- -
- Patients diagnosed with stage III or IV cancer by a specialist physician.
- Patients who agree to participate in the study after being informed about the research.
- Patients who are conscious and able to communicate in Mandarin or Taiwanese.
- Patients aged 20 years or older.
Key exclusion criteria (11 listed)
- -
- Patients in the experimental group and control group who reside in the same ward.
- Patients who share a ward with subjects already included in the study.
- Patients involved in ongoing medical disputes.
- Patients who cannot understand the study explanation due to language or cognitive impairments.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| life reviewAfter consenting, they will complete the first questionnaire before receiving the "Happiness Ledger" intervention via social media. Family members will have one week to organize photos, after which patients will share the meaning of the photos. This process will be recorded by the researcher and will last approximately 40 to 60 minutes. The researcher will then create a three-minute video using the photos, and the participating family members will assist in uploading the photos to the family LINE group as feedback to the subjects. The second questionnaire will then be completed. | Other | Experimental Group |
Primary outcome
Family Cohesion
Time frame: Baseline (pre-intervention) and 1 week after intervention
This study uses the Family Adaptability and Cohesion Evaluation Scale (FACES II) developed by Olson et al. (1979), which consists of 30 items to measure the family cohesion of patients and their families .
1 secondary outcome
Happiness
Time frame: Baseline and 1 week
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Aug 2024.
- Derived from this study: PubMed 41478730Yang WC, Li CY, Ho CL, Chang PY, Wu LF, Pan HH. Effectiveness of a Social Media-Based Life Review Intervention on Happiness in Advanced Cancer Patients and Their Family Caregivers: A Mixed-Methods Study. Psychooncology. 2026 Jan;35(1):e70374. doi: 10.1002/pon.70374.
- Individual participant dataSharing planned: No
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing life review in people with Cancer, run by YANG WEN-CHI.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 12 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 19 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Family Cohesion (time frame: Baseline (pre-intervention) and 1 week after intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06559917, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2024.